Drug Type Small molecule drug |
Synonyms Polycap, Polypill, Quintapill |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), COX inhibitors(Cyclooxygenases inhibitors), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date IN (14 Jul 2009), |
Regulation- |
Molecular FormulaC25H38O5 |
InChIKeyRYMZZMVNJRMUDD-HGQWONQESA-N |
CAS Registry79902-63-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Stroke | IN | 17 Jul 2009 | |
Coronary Disease | IN | 14 Jul 2009 | |
Coronary Artery Disease | - | - | |
Hypertension | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | TN | 07 Jun 2012 |
Not Applicable | 518 | (Two Doses of Low Strength Polycap) | ykowonvicz(mcliqeklmf) = xyhbwkrqpz dwfofhawvg (oxfshwhgiu, tpmhcxihqt - cgfqgeazzt) View more | - | 01 Dec 2014 | ||
Srength Polycap (One Dose of Low Srength Polycap) | ykowonvicz(mcliqeklmf) = udgqgqkaqq dwfofhawvg (oxfshwhgiu, cjdnkfdgfm - oghwcgptlr) View more | ||||||
Phase 2 | 2,053 | (qahqgfeetr) = ttxugvfwxh jsgbwxooaa (ncwbekyhvi, 0.62 - 0.78) | - | 18 Apr 2009 |